These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 15449112

  • 1. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma.
    Otsuka J, Okuda T, Sekizawa A, Amemiya S, Saito H, Okai T, Kushima M, Tachikawa T.
    Med Electron Microsc; 2004 Sep; 37(3):188-92. PubMed ID: 15449112
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
    Okuda T, Otsuka J, Sekizawa A, Saito H, Makino R, Kushima M, Farina A, Kuwano Y, Okai T.
    Gynecol Oncol; 2003 Mar; 88(3):318-25. PubMed ID: 12648581
    [Abstract] [Full Text] [Related]

  • 5. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
    Amemiya S, Sekizawa A, Otsuka J, Tachikawa T, Saito H, Okai T.
    Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
    [Abstract] [Full Text] [Related]

  • 6. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B, Hamada S, Kusuki I, Itoh R, Kitawaki J.
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [Abstract] [Full Text] [Related]

  • 7. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R, Khalifeh I, Bandyopadhyay S, Lawrence WD, Silva E, Liao D, Sarkar FH, Munkarah AR.
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [Abstract] [Full Text] [Related]

  • 8. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
    Jiang X, Morland SJ, Hitchcock A, Thomas EJ, Campbell IG.
    Cancer Res; 1998 Apr 15; 58(8):1707-12. PubMed ID: 9563487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F, Schmidt H, Buchweitz O, Malik E, Horny HP.
    Anticancer Res; 2004 Apr 15; 24(1):151-4. PubMed ID: 15015590
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y, Amatya VJ, Daimaru Y, Nakayori F, Nakano T, Inai K.
    Hum Pathol; 2001 Nov 15; 32(11):1203-8. PubMed ID: 11727259
    [Abstract] [Full Text] [Related]

  • 12. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D, Hirschmann A, Löhrs U, Diebold J.
    Gynecol Oncol; 2006 Dec 15; 103(3):883-7. PubMed ID: 16806438
    [Abstract] [Full Text] [Related]

  • 13. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.
    Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, Kamura T, Nakano H.
    Gynecol Oncol; 2000 May 15; 77(2):298-304. PubMed ID: 10785482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
    Suda K, Cruz Diaz LA, Yoshihara K, Nakaoka H, Yachida N, Motoyama T, Inoue I, Enomoto T.
    Cancer Sci; 2020 Aug 15; 111(8):3000-3009. PubMed ID: 32473611
    [Abstract] [Full Text] [Related]

  • 17. Endometriosis and the neoplastic process.
    Varma R, Rollason T, Gupta JK, Maher ER.
    Reproduction; 2004 Mar 15; 127(3):293-304. PubMed ID: 15016949
    [Abstract] [Full Text] [Related]

  • 18. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
    Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S, Matsubara O.
    J Pathol; 2011 Oct 15; 225(2):189-94. PubMed ID: 21735444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK, Su YF, Wu CC, Chen CC, Wang J, Hsieh TH, Herreros-Villanueva M, Chen WT, Chen YT, Liu TC, Chen HS, Tsai EM.
    J Mol Med (Berl); 2016 Jul 15; 94(7):835-47. PubMed ID: 26920370
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.